L, E., M, B., RK, L., JE, B., A, N., LA, C., . . . RW, J. (2009). The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy. Blood, 114(2), 380. https://doi.org/10.1182/blood-2008-10-182758
Chicago Style (17th ed.) CitationL, Ellis, et al. "The Histone Deacetylase Inhibitors LAQ824 and LBH589 Do Not Require Death Receptor Signaling or a Functional Apoptosome to Mediate Tumor Cell Death or Therapeutic Efficacy." Blood 114, no. 2 (2009): 380. https://doi.org/10.1182/blood-2008-10-182758.
MLA (9th ed.) CitationL, Ellis, et al. "The Histone Deacetylase Inhibitors LAQ824 and LBH589 Do Not Require Death Receptor Signaling or a Functional Apoptosome to Mediate Tumor Cell Death or Therapeutic Efficacy." Blood, vol. 114, no. 2, 2009, p. 380, https://doi.org/10.1182/blood-2008-10-182758.